Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20370930
Conclusion of this study
Treatment had therapeutic effects as evidenced by ultrasonography and the aminotransferase data. Hypolipidemic effects were also shown. We conclude that Spirulina maxima may be considered an alternative treatment for patients with non-alcoholic fatty liver diseases and dyslipidemic disorder.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study